Your browser doesn't support javascript.
loading
Impact of calcineurin inhibitors on rat glioma cells viability / 영남의대학술지
Yeungnam University Journal of Medicine ; : 105-108, 2019.
Article in English | WPRIM | ID: wpr-785313
ABSTRACT

BACKGROUND:

Although kidney transplantation outcomes have improved dramatically after using calcineurin inhibitors (CNIs), CNI toxicity continues to be reported and the mechanism remains uncertain. Here, we investigated the neurotoxicity of CNIs by focusing on the viability of glioma cells.

METHODS:

Glioma cells were treated with several concentrations of CNIs for 24 hours at 37℃ and their cell viability was evaluated using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay.

RESULTS:

Exposure to 0, 0.25, 0.5, 2.5, 5.0, and 10.0 mM concentrations respectively showed 100%, 64.3%, 61.3%, 68.1%, 62.4%, and 68.6% cell viability for cyclosporine and 100%, 38.6%, 40.8%, 43.7%, 37.8%, and 43.0% for tacrolimus. The direct toxic effect of tacrolimus on glioma cell viability was stronger than that of cyclosporine at the same concentration.

CONCLUSION:

CNIs can cause neurological side effects by directly exerting cytotoxic effects on brain cells. Therefore, we should carefully monitor the neurologic symptoms and level of CNIs in kidney transplant patients.
Subject(s)

Full text: Available Index: WPRIM (Western Pacific) Main subject: Brain / Cell Survival / Kidney Transplantation / Tacrolimus / Cyclosporine / Calcineurin / Calcineurin Inhibitors / Glioma / Kidney / Neurologic Manifestations Limits: Animals / Humans Language: English Journal: Yeungnam University Journal of Medicine Year: 2019 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Main subject: Brain / Cell Survival / Kidney Transplantation / Tacrolimus / Cyclosporine / Calcineurin / Calcineurin Inhibitors / Glioma / Kidney / Neurologic Manifestations Limits: Animals / Humans Language: English Journal: Yeungnam University Journal of Medicine Year: 2019 Type: Article